The collaborative testing program is in place. The commission talked about endocrine disruptors as a potential impact on reproductivity. The monitoring program we have in place has not detected any of the particular endocrine disruptors that were identified in the commission discussion. We are still continuing that monitoring program, because sometimes not finding anything doesn't mean it's not there but just that we haven't detected it.
That program in terms of a monitoring effort will continue. So far it has not identified a particular problem. I don't want it to sound like it has no result; it's just we haven't found it yet.